Thrombocytosis as a potential cause of a very late stent thrombosis in the left main coronary artery

Kardiol Pol. 2013;71(3):308-9. doi: 10.5603/KP.2013.0049.

Abstract

A 36 year-old man, who had undergone a paclitaxel-eluting stent deployment into the left main (LM) coronary artery three years before, was admitted after successful resuscitation following out-of-hospital cardiac arrest due to an acute ST-segment elevation myocardial infarction. Six weeks before the admission, he had discontinued clopidogrel. Coronary angiography showed a total occlusion of the LM artery. A complex percutaneous coronary intervention including thrombectomy and a second everolimus-eluting stent deployment in the LM artery and the left descending coronary artery was performed; this resulted in the restoration of TIMI 2/3 flow. A detailed investigation revealed an essential thrombocytosis necessitating treatment with hydroxyurea and indefinite dual antiplatelet therapy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Clopidogrel
  • Coronary Angiography
  • Coronary Stenosis / diagnostic imaging
  • Coronary Stenosis / etiology
  • Coronary Thrombosis / diagnostic imaging
  • Coronary Thrombosis / etiology*
  • Drug-Eluting Stents / adverse effects*
  • Humans
  • Male
  • Myocardial Infarction / diagnostic imaging
  • Myocardial Infarction / etiology
  • Myocardial Infarction / therapy
  • Out-of-Hospital Cardiac Arrest / etiology
  • Out-of-Hospital Cardiac Arrest / therapy
  • Paclitaxel / administration & dosage
  • Thrombocytosis / drug therapy
  • Thrombocytosis / etiology*
  • Ticlopidine / administration & dosage
  • Ticlopidine / analogs & derivatives
  • Withholding Treatment

Substances

  • Clopidogrel
  • Ticlopidine
  • Paclitaxel